Learn more about the exciting companies in Good Growth Capital’s portfolio:
Base is reinventing how companies manage the risk of having employees travel internationally, helping keep their personnel safe through a dashboard that connects to employees in the field. Base’s platform pulls information from multiple sources, including crowdsourced data to provide the most comprehensive picture of the situation on the ground.
DYNEPIC / playPORTAL
Dynepic is a women owned, veteran owned business that created the playPORTAL platform, the world’s only kid-safe engagement and privacy-certified platform powering connected play.
Sales & AI
Interloop delivers predictive sales analytics to give execs and managers new visibility into forecasts and at-risk deals, combined with insights and tools for reps in the field to take immediate action.
THE NEW PRIMAL
CPG, Healthy Snacks
Jerky, Meat Sticks, Snack Mates and Marinades are all certified gluten-free, paleo-friendly, artisanal quality, and minimally processed.
Pryon delivers enterprise-grade AI solutions that transform how customers develop and maximize relationships with their customers, employees, and partners.
PT ON DEMAND
Personalized Healthcare, Software
PTonDemand is an all inclusive office management and marketing platform that runs your office end to end. It includes online, seamless scheduling, intake, payment processing while integrating EMR, home exercise programs, and patient engagement tools.
Software, Ed Tech
The first automated engagement platform designed exclusively for education.
Questis is a team of former retirement advisors, passionate software engineers, and inspired visionaries who share one driving goal— to bring the value of personalized financial planning to everyone.
Republic gives customers access to a new and vast pool of capital. Raise funds from anyone: communities, customers, partners and millions of retail investors around the world.
Healthcare technology, Artificial Intelligence
ReviveMed is a precision-medicine platform that leverages data from metabolites.
This proprietary small molecule platform targets accelerates the discovery and development of drugs that correct RNA mis-splicing across a broad range of disease types.
Unison.cloud runs massively distributed Unison programs atop a worldwide elastic supply of managed Unison nodes, paying only for the resources used.